Interacting Drugs |
Rifapentine vs Everolimus |
Security Level |
|
Mechanism |
Everolimus: CYP3A4 Inducers (Strong) may decrease the serum concentration of Everolimus. |
Management |
Avoid concurrent use of strong CYP3A4 inducers, but if strong CYP3A4 inducers cannot be avoided, consider gradually (in 5 mg increments) increasing the everolimus dose from 10 mg/day to 20 mg/day (adult doses). |
Rifapentine vs Everolimus
Post Review about Rifapentine vs Everolimus Click here to cancel reply.
Other Interactions of Rifapentine
Other Interactions of Everolimus
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.